Effects of Switching From Smoking to Vaping on Clozapine Concentration–Dose Ratios and Plasma Clozapine Concentrations: A Systematic Review of Case Reports

INTRODUCTION: Smoking tobacco cigarettes affects the metabolism of several antipsychotic medications by inducing CYP1A2 enzymes. Clozapine is particularly sensitive to this effect, as CYP1A2 induction increases the plasma clearance of the drug, resulting in lower clozapine plasma concentrations and a reduced clozapine concentration-dose (C/D) ratio than that in nonsmokers. Although the increase in clozapine concentrations and C/D ratios after smoking cessation is well-established, the effects of switching to e-cigarettes (electronic cigarettes or vapes) or initiating vaping without prior smoking is not well-understood. This review aimed to address these gaps. METHODS: The literature was searched for articles on patients taking clozapine who used or had used e-cigarettes, including those who switched from tobacco cigarettes. Eligible publications were reviewed and information on patient demographics, psychiatric history, smoking status, clozapine dose, plasma clozapine concentrations, and C/D ratios before and after vaping were extracted. When not reported in the articles, the C/D ratio was calculated using the available plasma clozapine concentrations and corresponding clozapine dose. RESULTS: Five articles were identified, all case reports describing 5 patients (4 male) who switched from tobacco cigarettes to e-cigarettes while taking clozapine. Switching resulted in increased C/D ratios and plasma clozapine concentrations, although the magnitude of this increase varied among individuals. The most commonly reported symptoms after switching from smoking to vaping are constipation, fatigue, and visual changes. CONCLUSIONS: Based on the small number of case reports, complete switching from tobacco smoking to e-cigarette vaping may have a similar effect on clozapine plasma concentrations and C/D ratios as smoking cessation without vaping. The authors found no research on the impact of vaping on clozapine concentrations and C/D ratios in people who had never smoked.

Authors

Institutions

Publication Details

Journal
Therapeutic Drug Monitoring
Published
2026-05-27
DOI
https://doi.org/10.1097/ftd.0000000000001476
Primary Topic
Schizophrenia research and treatment
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Effects of Switching From Smoking to Vaping on Clozapine Concentration–Dose Ratios and Plasma Clozapine Concentrations: A Systematic Review of Case Reports

Hannah Walsh, Eve Taylor, Deborah Robson, Ann McNeill et al.
Therapeutic Drug Monitoring
Schizophrenia research and treatment
article

Effects of Switching From Smoking to Vaping on Clozapine Concentration–Dose Ratios and Plasma Clozapine Concentrations: A Systematic Review of Case Reports

Hannah Walsh, Eve Taylor, Deborah Robson, Ann McNeill, Somtochukwu D. Uche
article en

Abstract

INTRODUCTION: Smoking tobacco cigarettes affects the metabolism of several antipsychotic medications by inducing CYP1A2 enzymes. Clozapine is particularly sensitive to this effect, as CYP1A2 induction increases the plasma clearance of the drug, resulting in lower clozapine plasma concentrations and a reduced clozapine concentration-dose (C/D) ratio than that in nonsmokers. Although the increase in clozapine concentrations and C/D ratios after smoking cessation is well-established, the effects of switching to e-cigarettes (electronic cigarettes or vapes) or initiating vaping without prior smoking is not well-understood. This review aimed to address these gaps. METHODS: The literature was searched for articles on patients taking clozapine who used or had used e-cigarettes, including those who switched from tobacco cigarettes. Eligible publications were reviewed and information on patient demographics, psychiatric history, smoking status, clozapine dose, plasma clozapine concentrations, and C/D ratios before and after vaping were extracted. When not reported in the articles, the C/D ratio was calculated using the available plasma clozapine concentrations and corresponding clozapine dose. RESULTS: Five articles were identified, all case reports describing 5 patients (4 male) who switched from tobacco cigarettes to e-cigarettes while taking clozapine. Switching resulted in increased C/D ratios and plasma clozapine concentrations, although the magnitude of this increase varied among individuals. The most commonly reported symptoms after switching from smoking to vaping are constipation, fatigue, and visual changes. CONCLUSIONS: Based on the small number of case reports, complete switching from tobacco smoking to e-cigarette vaping may have a similar effect on clozapine plasma concentrations and C/D ratios as smoking cessation without vaping. The authors found no research on the impact of vaping on clozapine concentrations and C/D ratios in people who had never smoked.

Therapeutic Drug Monitoring
King's College London (GB), E Ink (South Korea) (KR)
Newcastle University, Cancer Research UK Cambridge Institute, University of Cambridge
Good health and well-being
Openalex Percentile: Top 6%
Schizophrenia research and treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.